YFYu Fu

Yu Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Fu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Hou

    1 shared publication
  • Daming Wang

    Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, Haidian 100191, China; Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Dongcheng, Beijing 100005, China

    1 shared publication
  • Danyang Tian

    Department of Neurology, Peking University Third Hospital

    1 shared publication
  • De-Xuan Kang

    1 shared publication
  • Deyong Lv

    Department of Radiology, Peking University Third Hospital, Beijing 100191, China; 2Beijing Key Laboratory of Magnetic Resonance Imaging Device and Technique, Beijing 100191, China; 3Department of Radiology, Dongying People's Hospital of Shandong, Shandong, 257091, China

    1 shared publication
  • Dong-Sheng Fan

    Department of Neurology, Peking University Third Hospital, Beijing 100191, China

    1 shared publication

Latest Publications

  • Open Access

    Estimated glomerular filtration rate in extracranial and intracranial atherosclerotic stenosis among patients with ischaemic stroke: a cross-sectional study

    by Danyang Tian, Xinran Ma, Yong Chen, Qiong Yang, Dongsheng Fan, Yu Fu

    Introduction: Kidney dysfunction has been associated with cerebrovascular atherosclerosis, but differences in renal measures between extracranial (ECAS) and intracranial atherosclerotic stenosis (ICAS) remain unclear. Methods: This hospital-based cross-sectional study included consecutive patients admitted with acute ischaemic stroke within 14 days of onset between January 2006 and December 2015 who were classified as having the large-artery atherosclerotic subtype. Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation adapted for Asian populations. Binary logistic regression compared ICAS with ECAS across four eGFR categories. The adjusted category model used complete cases; a sensitivity analysis used 50 multiply imputed datasets for missing covariates. Results: Among 1,127 patients with large-artery atherosclerotic stroke, 1,015 had ECAS or ICAS and available eGFR for the category analysis; 755 had complete covariate data. Compared with the highest eGFR category, the lowest two categories had lower adjusted odds of ICAS relative to ECAS in complete-case analyses (OR 0.38, 95% CI 0.21–0.68; and OR 0.50, 95% CI 0.28–0.88) and multiple-imputation analyses (OR 0.35, 95% CI 0.21–0.59; and OR 0.54, 95% CI 0.33–0.88). Proteinuria did not differ significantly between the groups, and eGFR was not significantly associated with stenosis severity within either group. Discussion: Lower eGFR was associated with extracranial rather than intracranial stenosis. Mechanistic explanations remain literature-derived and hypothesis-generating. The observational design and absence of diagnostic performance analyses preclude causal inference or conclusions about diagnostic utility or treatment selection.

  • Evaluating long-term outcomes of endovascular revascularization in symptomatic chronic internal carotid artery occlusion: A multicenter cohort study

    by Xiaoliang Yin, Xiaodong Chen, Jiachun Liu, Junjie Wang, Jun Lu, Qi Peng, Yiling Cai, Xiaogang Li, Yu Fu, Xumin Pan, et al.

  • Open Access

    Imaging and Quantitative Analysis of the Interstitial Space in the Caudate Nucleus in a Rotenone-Induced Rat Model of Parkinson’s Disease Using Tracer-based MRI

    by Deyong Lv, Jingbo Li, Hongfu Li, Yu Fu, Wei Wang

    Parkinson's disease (PD) is characterized by pathological changes within several deep structures of the brain, including the substantia nigra and caudate nucleus. However, changes in interstitial fluid (ISF) flow and the microstructure of the interstitial space (ISS) in the caudate nucleus in PD have not been reported. In this study, we used tracer-based magnetic resonance imaging (MRI) to quantitatively investigate the alterations in ISS and visualize ISF flow in the caudate nucleus in a rotenone-induced rat model of PD treated with and without madopar. In the rotenone-induced rat model, the ISF flow was slowed and the tortuosity of the ISS was significantly decreased. Administration of madopar partially prevented these changes of ISS and ISF. Therefore, our data suggest that tracer-based MRI can be used to monitor the parameters related to ISF flow and ISS microstructure. It is a promising technique to investigate the microstructure and functional changes in the deep brain regions of PD.


    • 12 October 2010
      • Vol. 90  (37) , 2629-32

    [Study of association between hyperIgEaemia and Hirayama disease].

    by Yu Fu, Qing-Li Sun, Hong-Bin Han, Chao Hou, Jun Zhang, De-Xuan Kang, Dong-Sheng Fan

    To investigate whether hyperIgEaemia is associated with Hirayama disease in China. Serum total IgE were examined in 123 patients and 82 control subjects from 2006 to 2009 at this hospital and their correlations with clinical profiles investigated. The data were analyzed by t, Chi-square and nonparametric tests. Past or present history of allergy/atopy was found in 14 (11.4%) patients and 11(13.4%)controls. The median value of serum total IgE were 87.97, 59.21 and 51.39 IU/ml in patients, controls and health controls respectively. There were no significant difference between the patient and control groups (Z = -0.947, P = 0.344) and the health control groups (Z = -0.914, P = 0.361). Serum IgE was elevated in 57 (43.6%) patients and 30 (36.6%) controls. HyperIgEaemia was present in 29 (23.6%) patients and 13 (15.9%) controls. There was no significant difference in the frequency of history of allergy/atopy, IgE elevation or hyperIgEaemia (P > 0.05) between cases and controls. Even after analyzing the length of duration or the severity of clinical disabilities, there was no difference neither (P > 0.05). Whether the length of duration or the severity of clinical disabilities, the serum total IgE level has no significant difference between all groups. HyperIgEaemia is not associated with Hirayama disease.